The Treasury consultation, Financing Growth in Innovative Firms - known more commonly as the Patient Capital Review - has now been published, and Chancellor Philip Hammond has urged "everyone with an interest… to respond".
The backdrop to the review is the gap between Britain's record in creating a fertile environment for start-up businesses and its performance helping those companies that are ready to take the next step...
Investors have piled into bonds such that more than $15trn worth are now negative yielding if held to maturity – a new record.
Knee-jerk reactions could become self-fulfilling
Poring through the FCA's new regulations
A fond farewell
What risk factors should investors look out for?